Deals & IPOs

Trader Targets $115 on Anthropic Stock Via New 2x ETF

Anthropic (ANT) fell to within five cents of its $83 IPO price on day two. Trader itsSweeped will buy the 2x AIL ETF Monday, targeting $115 — roughly $2.1 trillion — before the December 15 lockup expiry.

By Olivia Hart

3 min read

Long AIL (2x ANT) on Monday — $115 Target
Long AIL (2x ANT) on Monday — $115 TargetTheInvestorPost / pixabay

What's News

  • Anthropic (NASDAQ: ANT) IPO priced at $83 on Thursday, above the $70–$78 range, and first traded at $111.50, about 34% higher.
  • On Friday ANT fell to $83.05 — five cents above the IPO price — before closing at $88.30.
  • The trader cites Q3 revenue of about $17 billion versus $1.4 billion a year earlier, a more than 12x increase.
  • Of the $104 billion nine-month loss, roughly $94 billion stems from non-cash convertible-note accounting, mainly Amazon loans.
  • The plan: buy the 2x AIL ETF at Monday's open near $88 and sell around $115 (about $2.1 trillion) before December 15, when early investors can first sell.

A retail trader plans to buy a 2x leveraged ETF on Anthropic (NASDAQ: ANT) at Monday's open, aiming for a $115 per-share exit on a stock that touched that exact price on its first day of trading and fell straight back.

The trader, who posts on TradingView under the handle itsSweeped, laid out the plan in a note titled "Long AIL (2x ANT) on Monday — $115 Target." Anthropic, the company behind the Claude AI assistant, began trading on Thursday. The IPO priced at $83 — above a marketed range of $70 to $78 — and opened at $111.50, roughly 34% higher. Most of that pop then evaporated. On Friday, amid a broader selloff in AI and chip stocks, ANT traded as low as $83.05, five cents above the IPO price, before closing at $88.30.

Why the trader thinks the market is reading the wrong number

The figure dominating discussion, according to the trader, is Anthropic's $104 billion loss over nine months. "For most people that is enough to stay away," the trader wrote. But in their view, that headline number misleads.

About $94 billion of the loss comes from convertible notes — loans, mainly from Amazon, that convert into shares at a pre-agreed price. Each time Anthropic's valuation rose, the value of that conversion promise rose with it, and the accounting recorded the change as a loss. No cash left the company, the trader argues. Strip the non-cash item out, and the remaining loss is a fraction of the headline figure — though the trader offers no audited reconciliation of that arithmetic, and the source contains no company confirmation.

What does the revenue picture actually show?

The growth claims are the strongest part of the case. In the third quarter, Anthropic generated roughly $17 billion in revenue, against about $1.4 billion in the same quarter a year earlier — a more than twelvefold increase in twelve months. The trader notes the irony: "this is the slowdown everyone is worried about."

The valuation math is deliberately conservative. Assume growth never re-accelerates and each quarter simply adds the same $5.4 billion in revenue that the third quarter added. On that flat trajectory, annualized revenue reaches about $154 billion within a year. Against the IPO valuation of roughly $1.5 trillion, that works out to about 10 times revenue. In plain words: the trader believes the IPO price already works without any further speed-up in growth.

How exactly does the trade work?

The plan is specific, and the trader flags its own risks:

  • Buy AIL, the 2x leveraged ETF on ANT, at Monday's open as close to $88 as possible; chase nothing.
  • Take partial profits before December 15, when early investors are first permitted to sell shares.
  • Sell fully around $115 on ANT — approximately $2.1 trillion in market value, by the trader's math.
  • Exit before the first earnings report regardless.
  • No fixed stop loss yet; the position is deliberately smaller than usual.

The trader warns anyone unfamiliar with leveraged ETFs to read up on daily reset mechanics first, and states plainly: "If it goes far against my direction, I will close it in a loss!" They also decline to chase strength, citing Thursday's high of $115.10 — a touch of their exact target followed by an immediate reversal, a reminder the level has already rejected price once.

What is the so-what?

The trader describes their long-term view of Anthropic as honestly mixed and frames all of this as a short-term trade, closing the note with a disclaimer that it reflects a personal market view and is not financial advice. The setup hinges on one dated catalyst — the December 15 lockup expiry — and on the market agreeing, eventually, to look past a nine-month loss that the trader insists is mostly an accounting artifact rather than a cash drain.

By Olivia Hart

Source: tradingview.com

Share this article:

More from Olivia Hart

Olivia Hart

Show full bio

Staff writer covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.

2,535 articles

Related articles

« Previous article